Traws Pharma (TRAW)

Traws Pharma (TRAW) Financial Statements


Traws Pharma Financial Overview

Traws Pharma's market cap is currently ―. The company's EPS TTM is $-0.864; its P/E ratio is -0.53; Traws Pharma is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 56.00K$ 57.00K$ 57.00K$ 56.00K$ 56.00K
Gross Profit$ 56.00K$ 57.00K$ 57.00K$ 56.00K$ 56.00K
EBIT$ -4.98M$ -4.74M$ -4.25M$ -5.78M$ -6.07M
EBITDA$ -4.98M$ -4.73M$ -4.25M$ -5.77M$ -6.07M
Net Income Common Stockholders$ -4.98M$ -4.74M$ -4.25M$ -5.78M$ -5.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 29.73M$ 34.22M$ 38.76M
Total Assets$ 18.17M$ 27.04M$ 30.47M$ 35.06M$ 39.37M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 0.00$ 0.00$ -29.73M$ -34.22M$ -38.76M
Total Liabilities$ 12.16M$ 12.52M$ 11.57M$ 12.19M$ 11.06M
Stockholders Equity$ 6.01M$ 14.52M$ 18.90M$ 22.88M$ 28.31M
Cash Flow-
Free Cash Flow$ -4.42M$ -4.48M$ -4.49M$ -4.54M$ -3.88M
Operating Cash Flow$ -4.42M$ -4.47M$ -4.49M$ -4.54M$ -3.88M
Investing Cash Flow-$ -14.00K---
Financing Cash Flow-----
Currency in USD

Traws Pharma Earnings and Revenue History

Traws Pharma Debt to Assets

Traws Pharma Cash Flow

Traws Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis